6/27/2025CARsgen Submits NDA for Satri‑cel, Poised to Be First CAR‑T for Soli...

6/24/2025IASO Bio Highlights CAR-T MS Study Results at EAN 2025

6/24/2025BrightGene Reports Strong Phase 2 Results for Dual Agonist BGM0504 and...

6/24/2025Aclaris Launches Phase 1a/1b Study of ATI-052

6/23/2025Sciwind's Ecnoglutide Achieves 15.4% Weight Loss in Chinese Obesity Ph...

6/20/2025MindRank's Oral GLP-1RA MDR-001 Achieves Promising Phase IIb Results i...

6/20/2025Simcere Gains Approval to Market Insomnia Drug Quviviq in China

6/20/2025Lepu Begins MRG007 Trial in China, Licenses Global Rights to ArriVent

6/20/2025CanSinoBIO Obtained NDA Approval for its 13-Valent Pneumococcal Polysa...

6/18/2025FDA Clears Boan Biotech to Advance Innovative CD228‑Targeting ADC BA1...

6/18/2025Abbisko Launches Pivotal Irpagratinib Trial Targeting FGFR4-Driven Liv...

6/17/2025Merck's Long-Acting RSV Antibody Clesrovimab Recommended for Priority ...

6/16/2025CARsgen Delivers Deep Responses with CT071 in Newly Diagnosed Multiple...

6/16/2025Hengrui Presents Positive Phase 2 Obesity Data at ADA 2025

6/14/2025Keymed Biosciences' BsAb Shows Promise in Autoimmune Hemolytic Anemia

6/13/2025Kelun Cleared for Clinical Trial of SKB315 and Tagitanlimab Combo in C...

6/12/2025Viatris Wins NMPA Approval for Once‑Daily Nebulized COPD Therapy Yupe...

6/12/2025Dizal to Showcase Breakthrough Data on Hematologic Oncology Assets at ...

6/11/2025JW Pharma Wins China Approval for Ertapenem Injection

6/11/20253Sbio Powers Ahead in PD-1/VEGF Bispecific Race with Impressive Phase ...

6/10/2025Merck KGaA's Pimicotinib NDA Accepted by CDE in China, Setting Course ...

6/10/2025GenEditBio Doses First Patient in World’s First In Vivo CRISPR Trial ...

6/9/2025Everest Presents Positive Results from Phase 1b/2a Trial of EVER001 fo...

6/9/2025Sihuan's Chinese NDA for Breast Cancer Drug Bireociclib Accepted

6/9/2025YolTech's YOLT‑101 Wins FDA IND Clearance as China Licensee Salubris ...

6/9/2025Livzon's siRNA Candidate YJH‑012 Approved for Clinical Entry in China

6/9/2025Argo's siRNA Candidate BW‑00163 Enters Phase 2 for Hypertension

6/6/2025Beigene's BGB‑16673 Enters Phase 1b Trial for Chronic Urticaria in Ch...

6/6/2025Qilu Launches Phase III Trial of QL1706 + Bevacizumab

6/6/2025BMS's Reblozyl Approved in China for Lower‑Risk MDS‑Related Anemia

Page:16/22 Total number of articles:647: [First][<<] [14] [15] [16] [17] [18] [>>] [End]